(1 - 8 from 11
)
BRLI Announces InCellDx Investment and Launch of GenCerv Test Through its ...
www.marketwatch.com
[MarketWatch (press release)] of life threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis, and organ transplant rejection. Bio-Reference Laboratories, Inc. Tara Mackay, Investor Relations (fax) .
BioReference Laboratories, Inc. Announces Earnings Date for First...
www.globenewswire.com
... future developments or otherwise. www.bioreference.com. Tara Mackay Investor Relations Coordinator (201) (201) (fax).
Bio-Reference Laboratories, Inc. Reports Over 15% Increase in...
www.globenewswire.com
... or otherwise.www.bioreference.com · www.bioreference.com. Tara Mackay, Investor Relations (201) (201) (fax). Related ...
investor.wedbush.com
investor.wedbush.com
Tara Mackay, Investor Relations (201) (201) (fax) . Related Stocks: Bio-Reference Labs,
sorted by relevance / date